Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
35.14%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 305K | 35.14% | $ 868K |
| 3/31/2025 | $ 307K | 16.58% | $ 1.85M |
| 12/31/2024 | $ 309K | 13.64% | $ 2.27M |
| 9/30/2024 | $ 310K | 13.62% | $ 2.28M |
| 6/30/2024 | $ 312K | 12.98% | $ 2.4M |
| 3/31/2024 | $ 316K | 18% | $ 1.76M |
| 12/31/2023 | $ 318K | 23.04% | $ 1.38M |
| 9/30/2023 | $ 321K | 25.85% | $ 1.24M |
| 6/30/2023 | $ 327K | 31.5% | $ 1.04M |
| 3/31/2023 | $ 330K | 56.8% | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average DepAmor % has been 47.45%.
- The median DepAmor % for BIOXCEL THERAPEUTICS INC during this period was 24.44%
- BIOXCEL THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 235.04%.
- The lowest DepAmor % recorded by BIOXCEL THERAPEUTICS INC in the same timeframe 12.98%
BIOXCEL THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for BIOXCEL THERAPEUTICS INC is calculated as follows: DepAmor [ $ 81K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] BTAI - Depreciation and Amortization Margin, Last 5 years
12.98%
Minimum
Jun 30, 2024
235.04%
Maximum
Sep 30, 2022
47.45%
Average
24.44%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |